Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 32672-69-8
2. Mesoridazine Benzenesulfonate
3. Mesoridazine Besilate
4. Nc 123
5. Mesoridazine (besylate)
6. 10-(2-(1-methylpiperidin-2-yl)ethyl)-2-(methylsulfinyl)-10h-phenothiazine Benzenesulfonate
7. Nsc-760073
8. Mesoridazine Besylate [usp]
9. Mesoridazine (benzenesulfonate)
10. Chebi:6781
11. 32672-69-8 (besylate)
12. T4g2i958j2
13. 10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine Monobenzenesulfonate
14. (+-)-10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine Monobenzenesulfonate
15. Benzenesulfonic Acid;10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfinylphenothiazine
16. Mesoridazine Besylate (usp)
17. Lidanar; Lidanil; Mesoridazine Benzenesulfonate;nc 123
18. 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylsulfinyl)-10h-phenothiazine
19. Mesoridazine Besilate (10-[2-[(2rs)-1-methylpiperidin-2-yl]ethyl]-2-(methylsufhinyl)-10h-phenothiazine Besilate)
20. Smr000466274
21. Unii-t4g2i958j2
22. Sr-01000759425
23. 10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfinyl)-10h-phenothiazine Benzenesulfonate
24. Serentil (tn)
25. Prestwick_853
26. Prestwick0_000529
27. Schembl41229
28. Mls000758302
29. Mls001424031
30. Mls002222270
31. Mesoridazine Monobenzenesulfonate
32. Chembl1201052
33. Thioridazine-2-sulfoxide Besylate
34. Dtxsid10954368
35. Hms1569j19
36. Hms2051m09
37. Hms2096j19
38. Hms2234g16
39. Hms3369o09
40. Hms3393m09
41. Hms3713j19
42. Hms3885h21
43. Pharmakon1600-01505500
44. Hy-b1482
45. Mesoridazine Besylate [vandf]
46. Nsc760073
47. Mesoridazine Besilate [mart.]
48. Mesoridazine Besilate [who-dd]
49. Mesoridazine Besylate [usp-rs]
50. Ccg-100781
51. Ccg-213471
52. Nc00031
53. Nsc 760073
54. 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-, (+-)-, Monobenzenesulfonate
55. 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-, Monobenzenesulfonate
56. Benzenesulfonic Acid, Compd. With 10-(2-(1-methyl-2-piperidinyl)ethyl)- 2-(methylsulfinyl)ethyl)-10h-phenothiazine (1:1)
57. Mesoridazine Benzenesulfonate [mi]
58. Smr000449304
59. Mesoridazine Besylate [orange Book]
60. (s)-(-)-diaminopropanetartaricacid
61. Mesoridazine Besylate [usp Impurity]
62. Cs-0013182
63. Sw196983-4
64. D00795
65. J-018829
66. Sr-01000759425-6
67. Mesoridazine Benzenesulfonate, >=98% (hplc), Powder
68. Q27107329
69. Mesoridazine Besylate, United States Pharmacopeia (usp) Reference Standard
70. 10-(2-(1-methylpiperidin-2-yl)ethyl)-2-(methylsulfinyl)-10h-phenothiazinebenzenesulfonate
71. (+/-)-10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulfinyl)phenothiazine Monobenzenesulfonate
72. (+/-)-10-(2-(1-methyl-2-piperidyl)ethyl)-2-(methylsulphinyl)phenothiazine Monobenzenesulphonate
73. 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulfinyl)-, (+/-)-, Monobenzenesulfonate
74. 10h-phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylsulphinyl)-, (+/-)-, Monobenzenesulphonate
75. Benzenesulfonic Acid--2-(methanesulfinyl)-10-[2-(1-methylpiperidin-2-yl)ethyl]-10h-phenothiazine (1/1)
| Molecular Weight | 544.8 g/mol |
|---|---|
| Molecular Formula | C27H32N2O4S3 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 5 |
| Exact Mass | 544.15242103 g/mol |
| Monoisotopic Mass | 544.15242103 g/mol |
| Topological Polar Surface Area | 131 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 686 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Mesoridazine Besylate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Mesoridazine Besylate, including repackagers and relabelers. The FDA regulates Mesoridazine Besylate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Mesoridazine Besylate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Mesoridazine Besylate supplier is an individual or a company that provides Mesoridazine Besylate active pharmaceutical ingredient (API) or Mesoridazine Besylate finished formulations upon request. The Mesoridazine Besylate suppliers may include Mesoridazine Besylate API manufacturers, exporters, distributors and traders.
click here to find a list of Mesoridazine Besylate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Mesoridazine Besylate DMF (Drug Master File) is a document detailing the whole manufacturing process of Mesoridazine Besylate active pharmaceutical ingredient (API) in detail. Different forms of Mesoridazine Besylate DMFs exist exist since differing nations have different regulations, such as Mesoridazine Besylate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Mesoridazine Besylate DMF submitted to regulatory agencies in the US is known as a USDMF. Mesoridazine Besylate USDMF includes data on Mesoridazine Besylate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Mesoridazine Besylate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Mesoridazine Besylate suppliers with USDMF on PharmaCompass.
Mesoridazine Besylate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Mesoridazine Besylate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Mesoridazine Besylate GMP manufacturer or Mesoridazine Besylate GMP API supplier for your needs.
A Mesoridazine Besylate CoA (Certificate of Analysis) is a formal document that attests to Mesoridazine Besylate's compliance with Mesoridazine Besylate specifications and serves as a tool for batch-level quality control.
Mesoridazine Besylate CoA mostly includes findings from lab analyses of a specific batch. For each Mesoridazine Besylate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Mesoridazine Besylate may be tested according to a variety of international standards, such as European Pharmacopoeia (Mesoridazine Besylate EP), Mesoridazine Besylate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Mesoridazine Besylate USP).
LOOKING FOR A SUPPLIER?
